dan 2163 has been researched along with epidepride in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bressan, RA; Ell, PJ; Erlandsson, K; Flanagan, RJ; Jones, HM; Mulligan, R; Pilowsky, LS | 1 |
Bressan, RA; Ell, PJ; Erlandsson, K; Pilowsky, LS; Stone, JM | 1 |
1 trial(s) available for dan 2163 and epidepride
Article | Year |
---|---|
Non-uniform blockade of intrastriatal D2/D3 receptors by risperidone and amisulpride.
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzamides; Binding, Competitive; Brain Mapping; Case-Control Studies; Corpus Striatum; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Female; Humans; Iodine Isotopes; Male; Pyrrolidines; Receptors, Dopamine D3; Risperidone; Schizophrenia; Sulpiride; Tomography, Emission-Computed, Single-Photon | 2005 |
1 other study(ies) available for dan 2163 and epidepride
Article | Year |
---|---|
Is regionally selective D2/D3 dopamine occupancy sufficient for atypical antipsychotic effect? an in vivo quantitative [123I]epidepride SPET study of amisulpride-treated patients.
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzamides; Corpus Striatum; Dopamine D2 Receptor Antagonists; Female; Humans; Iodine Radioisotopes; Limbic System; Male; Middle Aged; Pyrrolidines; Receptors, Dopamine D2; Receptors, Dopamine D3; Schizophrenia; Sulpiride; Temporal Lobe; Thalamus; Tomography, Emission-Computed, Single-Photon | 2003 |